International Companies
Xerox beats on profits, falls short on revenues
Xerox beat Wall Street estimates for profits on Tuesday as cost-cutting exercises implemented by activist investors Carl Icahn and Darwin Deason in their first quarter in control of the photocopier were successful.
Caterpillar shares sink following weak outlook
Heavy machinery manufacturer Caterpillar reiterated its disappointing guidance for the full year on Tuesday, blaming its woes on rising costs coming as a result of the US and China's tit-for-tat trade war.
McDonald's sales top estimates, plans to revamp breakfast menu
Fast food giant McDonald's turned in its third-quarter results on Tuesday, topping analysts' estimates on both the top and bottom line.
US auto market 'dominated by Tesla', says short-seller Citron
Tesla’s shares were boosted on Tuesday after short-seller Citron, a long-time critic of the electric car company, unexpectedly reversed its position on the stock from ‘short’ to ‘long’.
Helios & Matheson jumps over plan to spin off MoviePass
Shares in Helios & Matheson Analytics rocketed 81% after the company announced its plans to spin off its subsidiary MoviePass as a separate company.
Bayer stumbles after Monsanto cancer decision reversed
Bayer stock fell on Tuesday after a US court rejected its Monsanto arm's appeal to overturn a jury verdict linking its Roundup weedkiller to cancer.
Biogen beats the Street on Spinraza growth
US biotech Biogen saw third-quarter profits come in ahead of analysts' estimates as a result of double-digit sales growth of its muscular atrophy treatment Spinraza.
United Technologies raises guidance following stronger-than-expected demand
United Technologies upped its full-year earnings guidance for the third time in a year on Tuesday on the back of a stronger than expected set of quarterly earnings.
Idorsia leaves guidance unchanged after third quarter losses
Idorsia announced its financial results for the first nine months of 2018 on Tuesday, reporting a loss of CHF 271m on a US GAAP basis for the period, and a non-GAAP loss of CHF 247m.
Pharma veteran Simon Jose joining Idorsia as chief commercial officer
Idorsia confirmed on Tuesday that Simon Jose would join the company as chief commercial officer on 1 December, and would also be a member of the company’s executive committee.